Effectiveness of conduction system pacing for cardiac resynchronization therapy: A systematic review and network

Hamed Tavolinejad1, Sina Kazemian1, Ali Bozorgi1

  • 1Department of Cardiac Electrophysiology, Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Insights

Conduction system pacing cardiac resynchronization therapy (CSP-CRT), including His pacing (His-CRT) and left bundle branch pacing (LBB-CRT), offers improved outcomes over biventricular CRT. LBB-CRT shows particular promise with lower pacing thresholds and high success rates.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Biventricular cardiac resynchronization therapy (BiV-CRT) is ineffective in about one-third of patients, necessitating alternative pacing strategies.
  • Conduction system pacing (CSP-CRT) aims to improve cardiac synchronization by pacing the heart's native conduction system.

Approach:

  • A systematic literature review and meta-analysis compared His pacing (His-CRT) and left bundle branch pacing (LBB-CRT) against BiV-CRT.
  • Data from 37 publications, including 20 comparative studies, were analyzed for efficacy, QRS duration, ejection fraction, and clinical outcomes.

Key Points:

  • Both His-CRT and LBB-CRT demonstrated greater improvements in QRS duration, left ventricular ejection fraction, and New York Heart Association class compared to BiV-CRT.
  • LBB-CRT exhibited higher success rates (91.5%) and lower pacing thresholds than His-CRT (73.5%) and BiV-CRT.
  • CSP-CRT was associated with reduced mortality and hospitalization risks.

Conclusions:

  • CSP-CRT, particularly LBB-CRT, offers significant advantages over BiV-CRT in terms of electrical and clinical synchronization.
  • LBB-CRT presents a promising alternative due to its high efficacy and favorable pacing parameters.
  • Further randomized trials are warranted to definitively establish the long-term efficacy of CSP-CRT.
Abstract

Related Concept Videos

Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
8.3K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
5.6K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
13
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19